
51 - 200 employees
Founded 2012
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Debt on 2026-09
Biotechnology • Pharmaceuticals
Viking Therapeutics, Inc. is a clinical-stage biotechnology company advancing next-generation therapies for obesity and metabolic and endocrine disorders. The company’s lead program, VK2735, is a dual GLP-1/GIP receptor agonist being developed as both oral and injectable formulations and is in Phase 3 obesity studies. Viking’s pipeline also includes programs targeting metabolic and liver diseases (e. g. , VK2809) and next-generation approaches such as amylin-based therapies. The company emphasizes treating obesity as a chronic disease to achieve long-term health benefits including improved cardiovascular health, physical function, and quality of life.
🔥 8 minutes ago
Where this job comes from
Posted on Viking Therapeutics, Inc.'s careers page, not through a job board
First seen by Remote Rocketship 8 minutes ago

51 - 200 employees
Founded 2012
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Debt on 2026-09
Biotechnology • Pharmaceuticals
Viking Therapeutics, Inc. is a clinical-stage biotechnology company advancing next-generation therapies for obesity and metabolic and endocrine disorders. The company’s lead program, VK2735, is a dual GLP-1/GIP receptor agonist being developed as both oral and injectable formulations and is in Phase 3 obesity studies. Viking’s pipeline also includes programs targeting metabolic and liver diseases (e. g. , VK2809) and next-generation approaches such as amylin-based therapies. The company emphasizes treating obesity as a chronic disease to achieve long-term health benefits including improved cardiovascular health, physical function, and quality of life.
• Develop and execute territory plans engaging key opinion leaders, clinical investigators, centers of excellence, health systems, and professional societies • Establish and maintain peer-to-peer relationships with external experts and healthcare professionals • Deliver scientifically balanced, evidence-based presentations • Respond to unsolicited medical information requests in compliance with company policy and regulations • Identify healthcare professional educational needs and provide tailored scientific content • Support clinical trial site identification, feasibility assessment, and investigator engagement • Provide scientific support to active and prospective trial sites and facilitate communication with Clinical Operations • Gather and synthesize field insights on clinical practice, treatment paradigms, unmet needs, and competitive landscape • Identify evidence gaps and contribute to medical strategy and publication planning • Collaborate with Clinical Development, Regulatory, Medical Information, and other cross-functional partners • Serve as a scientific resource at medical congresses, advisory boards, roundtables, and investigator meetings • Support external expert identification and speaker training • Participate in MSL strategy, training, and operations project teams • Contribute to field medical metrics, dashboards, and SOPs • Document field interactions and insights in the assigned CRM or system • Complete required training and administrative tasks on time • Remain current on emerging literature, treatment guidelines, and competitive landscape • Ensure activities comply with applicable laws, regulations, industry codes, and Viking policies
• Advanced doctoral degree in life or clinical sciences (Pharm.D., Ph.D., M.D., D.O., or equivalent); nurse practitioner or physician assistant degrees will be considered • At least 3 years of experience in the pharmaceutical or biotechnology industry, a health system, or a related clinical research setting • Prior MSL experience strongly preferred • Deep scientific knowledge of obesity, endocrinology, metabolism, or a related therapeutic area • Established relationships within the obesity and cardiometabolic medical community preferred • Strong understanding of obesity and cardiometabolic disease, including treatment approaches, emerging therapies, and relevant scientific literature • Ability to critically evaluate clinical data and communicate complex scientific information clearly to diverse healthcare audiences • Excellent scientific presentation and interpersonal skills • Knowledge of clinical trial processes, including site identification, feasibility assessment, and investigator engagement • Understanding of compliance requirements governing scientific exchange, medical information responses, and field medical activities • Ability to gather and synthesize field insights, identify evidence gaps, and communicate findings to inform medical strategy • Strong territory planning, organizational, and time management skills • Ability to collaborate effectively with Medical Affairs, Clinical Development, Clinical Operations, Regulatory, and other cross-functional teams • Proficiency in CRM systems and accurate, timely documentation of field interactions and insights • Valid driver's license • Ability to travel 50–75%, primarily within the assigned territory, by car and air
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 26 minutes ago
Medical Science Liaison supporting ADC Therapeutics’ antibody-drug conjugate cancer therapies across NC, SC and GA. Providing scientific education, KOL engagement and field insights to advance Medical Affairs.
🔥 26 minutes ago
Medical Science Liaison providing scientific guidance on ADC Therapeutics’ cancer therapies across New England. Building KOL relationships and collecting field insights for Medical Affairs.
🔥 26 minutes ago
Medical Science Liaison providing scientific guidance on ADC Therapeutics’ antibody-drug conjugate therapies. Building hematology/oncology relationships and gathering field insights across MD, VA and West Virginia.
🔥 13 hours ago
Medical Science Liaison advancing Guardant Health’s precision oncology diagnostics through physician education, KOL collaboration, and clinical insight. Remote Kansas City role with extensive travel.
🔥 19 hours ago
Senior Medical Science Liaison advancing Lundbeck’s rare epilepsy therapies through KOL engagement and scientific insights. Supporting evidence strategy, disease education, clinical development, and launch readiness.
🇺🇸 United States – Remote
💵 $190k - $220k / year
💰 $566.4M Post-IPO Debt - Lundbeck on 2025-05
⏰ Full Time
🟠 Senior